← Back to Dashboard

ZX-7101A

Cap-dependent endonuclease inhibitor

2D Structure

Structure not available

3D Structure

Loading 3D structure...

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Influenza A virus
FLUAV
Target: Viral endonuclease
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
China
Approval ref (english.nmpa.gov.cn) Brand Zaitongwei (再通卫)NMPA approved 2024 for influenzabaloxavir-class